Shara Elrod, PharmD, BCACP

Shara Elrod, PharmD, BCACP

Associate Professor of Pharmacotherapy

 

Education & Experience:

I received a BS in Biology from Texas A&M University and a PharmD from The University of Texas at Austin College of Pharmacy. I completed a PGY-1 residency in Community Pharmacy and a PGY-2 specialty residency in Ambulatory Care at the University of Pittsburgh Medical Center. Previously, I was faculty at Nova Southeastern University College of Pharmacy in Ft Lauderdale, FL.

Teaching Areas & Interests:

Thus far, my teaching focus has been in the area of therapeutics, specifically hypertension and hyperlipidemia. In my last position, I adapted the active learning strategy “Think-Pair-Share” to utilize technology in the classroom and engage students in clinical problem solving across 4 different classrooms.

Professional Activities & Awards:

I am a member of American College of Clinical Pharmacy and American Pharmacists Association. I also served a Co-advisor for the Nova Southeastern University American Pharmacists Association – Academy of Student Pharmacists. Additionally, I served on the Education Affairs Council as a member of the Florida Pharmacists Association and the Membership Committee while a member of the Pennsylvania Pharmacists Association.

Scholarly Interests:

Currently, I am part of two grant-funded clinical trials examining the use of short message system (i.e. text messages) on medication adherence in patients with diabetes and with HIV/AIDS. Additionally, I am certified by the Broward County Health Department to provide rapid HIV tests. I worked as a part of an interdisciplinary team in Broward County to provide rapid HIV testing, where I focused on partners and caregivers of HIV-infected individuals. My research has focused separately on ambulatory care and HIV, but in the future I am looking to combine these two areas of interest and assess the treatment of non-communicable chronic diseases in people living with HIV/AIDS.

Link to Dr. Elrod’s University Profile

This page was last modified on October 4, 2018